Stellate Therapeutics is an international biotech company with locations in
Stellate Therapeutics is an international biotech company with locations in:
Bacteria have co-evolved with humans and have become critical to maintaining our health
Recent studies have shown that our gut microbiome impacts brain diseases
Microbiome-made molecules are an ideal source for potential new treatments because they are endogenous and therefore less likely to be toxic
Stellate’s microbiome-derived medicine platform leverages trillions of human gut bacteria to:
Stellate Therapeutics is an international biotechnology company
with locations in Paris, France and NYC, USA focused on the use of small molecules to
treat neurodegenerative disorders. Through millions of years of co-evolution, humans
have developed a symbiotic relationship with our microbiome. Metabolites that our
microbiome generate contribute to homeostasis, health and wellbeing. By exploring the
interaction and function of these molecules in disease states, Stellate hopes to develop
therapeutics that address unmet needs in a number of neurological conditions. Our lead
candidate STL-101 is in the preclinical stage of development
for treatment of Parkinson’s disease.
Director, Business Dev.